Martens Juergen

Avg. Two Year Performance

32% Avg. Purchase Return
15% Compound
86% Avg. Sale Return
36% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%(17%)(28%)(7%)32%
Purchase Success Rate4 of 61 of 62 of 62 of 63 of 6
Average Sale Return< 1%12%20%39%86%
Sale Success Rate7 of 149 of 148 of 149 of 1414 of 14
Drugs » Biotechnology

Corporate VP and COO:

Holdings: 106.54K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drugs - Generic

Chief Tech/Operations Officer:

Holdings: 25.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--